We are live on ! Find out more
TCRX icon

TScan Therapeutics
TCRX

81 hedge funds and large institutions have $51.8M invested in TScan Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 18

6% less capital invested

Capital invested by funds: $55.4M → $51.8M (-$3.57M)

8.44% less ownership

Funds ownership: 76.73% → 68.29% (-8.4%)

12% less funds holding

Funds holding: 92 → 81 (-11)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

34% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 32

Holders
81
Holders Change
-11
Holders Change %
-11.96%
% of All Funds
1.07%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
21
Increased
26
Reduced
18
Closed
32
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LCM
Lynx1 Capital Management
Puerto Rico
+$3.61M
2
Renaissance Technologies
Renaissance Technologies
New York
+$899K
3
Millennium Management
Millennium Management
New York
+$576K
4
BI
BVF Inc
California
+$486K
5
UBS Group
UBS Group
Switzerland
+$400K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$4.83M
2
BlackRock
BlackRock
New York
-$3.34M
3
CC
Checkpoint Capital
California
-$2.78M
4
EC
EcoR1 Capital
California
-$915K
5
State Street
State Street
Massachusetts
-$891K
Name Holding Trade Value Shares
Change 		Change in
Stake
PFSRSONJ
101
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$10.7K -7,720 Closed
New York State Common Retirement Fund
102
New York State Common Retirement Fund
New York
– -$8.51K -6,169 Closed
Legal & General Group
103
Legal & General Group
United Kingdom
– -$5.43K -3,937 Closed
AIP
104
Ameritas Investment Partners
Nebraska
– -$5.19K -3,762 Closed
California State Teachers Retirement System (CalSTRS)
105
California State Teachers Retirement System (CalSTRS)
California
– -$3.84K -2,782 Closed
AB
106
Amalgamated Bank
New York
– -$2K -1,329 Closed
Royal Bank of Canada
107
Royal Bank of Canada
Ontario, Canada
– -$1.51K -1,046 -94%
CCM
108
Coldstream Capital Management
Washington
– -$766 -555 Closed
PD
109
Point72 (DIFC)
United Arab Emirates
– -$678 -492 Closed
SCM
110
Sterling Capital Management
North Carolina
– -$357 -259 Closed
CA
111
CoreCap Advisors
Michigan
– -$229 -166 Closed
RIL
112
Rothschild Investment LLC
Illinois
– -$152 -110 Closed
IA
113
IFP Advisors
Florida
– -$10 -7 Closed
1 2 3 4
5

TCRX Hedge Fund Activity: Q2 2025 in Review

81 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in TScan Therapeutics (TCRX) for Q2 2025, worth a combined $51.8M — down 6.4% from $55.4M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of TCRX and 21 opened new positions — a net loss of 11 holders — while 18 trimmed existing stakes and 26 added.

The largest buyer was Lynx1 Capital Management, adding an estimated $3.61M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $4.83M sold.

  • 81 institutional investors held TScan Therapeutics (TCRX) as of Q2 2025, down from 92 in Q1 2025.
  • Funds reported $51.8M of TScan Therapeutics stock for Q2 2025, down 6.4% quarter-over-quarter.
  • 21 funds opened new TScan Therapeutics positions in Q2 2025 and 32 closed out, a net change of -11 holders.
  • The largest TScan Therapeutics buyer in Q2 2025 was Lynx1 Capital Management, an estimated $3.61M added.
  • The largest TScan Therapeutics seller in Q2 2025 was Adage Capital Partners, an estimated $4.83M sold.

Based on aggregated 13F filings for Q2 2025.